Ditchcarbon
  • Customers
  1. Organizations
  2. Assertio Holdings, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Assertio Holdings, Inc.

Company website

Assertio Holdings, Inc., commonly referred to as Assertio, is a prominent biopharmaceutical company headquartered in the United States. Founded in 2013, Assertio has established itself within the specialty pharmaceutical industry, focusing on the development and commercialisation of innovative treatments for pain management and neurology. With a strong operational presence across North America, Assertio is renowned for its unique portfolio of prescription medications, including its flagship product, Zipsor, which offers a novel approach to pain relief. The company has achieved significant milestones, including strategic acquisitions that have bolstered its market position and expanded its therapeutic offerings. Assertio's commitment to improving patient outcomes through targeted therapies underscores its reputation as a leader in the biopharmaceutical sector.

DitchCarbon Score

How does Assertio Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Assertio Holdings, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Assertio Holdings, Inc.'s reported carbon emissions

Assertio Holdings, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, Assertio Holdings, Inc. does not inherit emissions data from any parent or related organizations, and there are no commitments to science-based targets (SBTi) or other industry-standard climate initiatives. This lack of data and commitments suggests that Assertio Holdings, Inc. may need to enhance its climate strategy to align with industry best practices and address the growing importance of sustainability in corporate governance.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Assertio Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Assertio Holdings, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Assertio Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

ANI Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Nektar Therapeutics

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Ethypharm SAS

FR
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

ADVANZ PHARMA Corp. Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Sagent Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Human Genome Sciences Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy